Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · derivative · entry 6 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,434 Underlying: Common Stock · 1,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028. F3 · derivative.expiration_date: One-third of these RSUs vested on October 1, 2026. The remaining RSUs vest one-half on October 1, 2027 and one-half on October 1, 2028. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Exercise / conversionRestricted Stock Units · Derivative | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · derivative · entry 5 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,368 shares Expires 2026-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Tax withholdingCommon Stock | 480 | $88.42 | $42,441.60 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 4 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,174 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Exercise / conversionCommon Stock | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 3 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Tax withholdingCommon Stock | 932 | $88.42 | $82,407.44 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 2 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,436 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:12 UTC |
Campbell Gary CraigPresident, Americas
|
Exercise / conversionCommon Stock | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0002155115-26-000003 · form4-10052026_081009.xml · nonDerivative · entry 1 Campbell Gary Craig · CIK 0002155115 · President, Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:12 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 173.901 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001910621-26-000010 · form4-10022026_081024.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,171.359 Underlying: Common Stock · 173.901 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.276 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:11 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 173.901 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001689392-26-000012 · form4-10022026_081033.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,033.757 Underlying: Common Stock · 173.901 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 17.252 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:16 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 153.033 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001999146-26-000010 · form4-10022026_081019.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,865.311 Underlying: Common Stock · 153.033 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 9.178 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:14 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 375.626 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001587868-26-000016 · form4-10022026_081022.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,392.107 Underlying: Common Stock · 375.626 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:21 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 306.066 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001222676-26-000012 · form4-10022026_081035.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,660.84 Underlying: Common Stock · 306.066 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 85.331 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:24 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 417.363 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001485164-26-000010 · form4-10022026_081058.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,073.731 Underlying: Common Stock · 417.363 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 49.652 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 00:19 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 306.066 | $0.00 Strike: $89.85 | $0.00 |
DisclosureSEC source: 0001142083-26-000010 · form4-10022026_081008.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,077.496 Underlying: Common Stock · 306.066 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 96.739 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:24 UTC |
Thornal Kevin RGrp Pres-Global Business
|
SaleCommon Stock | 5,691 | $92.95 | $528,978.45 |
DisclosureSEC source: 0001783992-26-000006 · form4-09152026_080921.xml · nonDerivative · entry 1 Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:12 UTC |
Phipps Chad FSee remarks below.
|
SaleCommon Stock | 3,000 | $98.35 | $295,050.00 |
DisclosureSEC source: 0001346672-26-000010 · form4-09092026_080951.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,231 F1 · balance_after: Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:08 UTC |
Desai ChintanPresident, APAC
|
GrantRestricted Stock Units · Derivative | 10,168 | $0.00 | $0.00 |
DisclosureSEC source: 0002136215-26-000006 · form4-08052026_080820.xml · derivative · entry 1 Desai Chintan · CIK 0002136215 · President, APAC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,168 Underlying: Common Stock · 10,168 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029. F2 · derivative.expiration_date: One-third of the RSUs shall vest on each of August 3, 2027, August 3, 2028 and August 3, 2029. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 20:18 UTC |
Thornal Kevin RGrp Pres-Global Business
|
Exercise / conversionRestricted Stock Units · Derivative | 9,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001783992-26-000004 · form4-08042026_080809.xml · derivative · entry 3 Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,913 Underlying: Common Stock · 9,957 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028. F3 · derivative.expiration_date: One-third of the RSUs vested on August 1, 2026. The remaining RSUs vest one-half on each of August 1, 2027 and August 1, 2028. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 20:18 UTC |
Thornal Kevin RGrp Pres-Global Business
|
Tax withholdingCommon Stock | 4,266 | $92.68 | $395,372.88 |
DisclosureSEC source: 0001783992-26-000004 · form4-08042026_080809.xml · nonDerivative · entry 2 Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,691 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 20:18 UTC |
Thornal Kevin RGrp Pres-Global Business
|
Exercise / conversionCommon Stock | 9,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001783992-26-000004 · form4-08042026_080809.xml · nonDerivative · entry 1 Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:44 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 389.498 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001587868-26-000012 · form4-07022026_090709.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,983.867 Underlying: Common Stock · 389.498 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:43 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 180.323 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001910621-26-000008 · form4-07022026_090727.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,990.182 Underlying: Common Stock · 180.323 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:23 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 317.369 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001222676-26-000010 · form4-07022026_080747.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,269.443 Underlying: Common Stock · 317.369 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:22 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 317.369 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001142083-26-000008 · form4-07022026_080754.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,674.691 Underlying: Common Stock · 317.369 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:22 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 180.323 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001689392-26-000010 · form4-07022026_080701.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,842.604 Underlying: Common Stock · 180.323 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:21 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 432.776 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001485164-26-000008 · form4-07022026_080717.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,606.716 Underlying: Common Stock · 432.776 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:20 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 158.684 | $0.00 Strike: $86.65 | $0.00 |
DisclosureSEC source: 0001999146-26-000008 · form4-07022026_080736.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,703.1 Underlying: Common Stock · 158.684 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:31 UTC |
Noor JehanzebSee remarks below.
|
GrantRestricted Stock Units · Derivative | 1,857 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000006 · form4-06032026_080620.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,857 Underlying: Common Stock · 1,857 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing June 1, 2027. Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:35 UTC |
Yi SangGroup President, Asia Pacific
|
SaleCommon Stock | 800 | $82.66 | $66,128.00 |
DisclosureSEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,251 Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:35 UTC |
Yi SangGroup President, Asia Pacific
|
SaleCommon Stock | 4,200 | $82.64 | $347,088.00 |
DisclosureSEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,051 Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:14 UTC |
Farrell Michael J.Director
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001485164-26-000006 · form4-05272026_080533.xml · derivative · entry 2 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,757 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:14 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001485164-26-000006 · form4-05272026_080533.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,173.94 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 53.557 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:13 UTC |
BERNARD BETSY JDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001166854-26-000002 · form4-05272026_080534.xml · derivative · entry 2 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,506 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:13 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001166854-26-000002 · form4-05272026_080534.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,581.562 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 60.604 phantom stock units accrued on April 30, 2026, 57.375 phantom stock units accrued on January 30, 2026, 49.323 phantom stock units accrued on October 31, 2025 and 53.221 phantom stock units accrued on July 31, 2025, in each case under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:12 UTC |
Hilado Maria TeresaDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001587868-26-000008 · form4-05272026_080549.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,098 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as of a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:12 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001587868-26-000008 · form4-05272026_080549.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,594.369 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 34.300 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:12 UTC |
Shapiro LouisDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001999146-26-000006 · form4-05272026_080511.xml · derivative · entry 2 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,991.063 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:12 UTC |
Shapiro LouisDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001999146-26-000006 · form4-05272026_080511.xml · derivative · entry 1 Shapiro Louis · CIK 0001999146 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,544.416 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 7.812 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:11 UTC |
Kurdikar DevdattDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 2 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,922.072 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:11 UTC |
Kurdikar DevdattDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001910621-26-000006 · form4-05272026_080533.xml · derivative · entry 1 Kurdikar Devdatt · CIK 0001910621 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809.859 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 5.662 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:10 UTC |
Kolli SreelakshmiDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001689392-26-000008 · form4-05272026_080551.xml · derivative · entry 2 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,875 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:10 UTC |
Kolli SreelakshmiDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001689392-26-000008 · form4-05272026_080551.xml · derivative · entry 1 Kolli Sreelakshmi · CIK 0001689392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,662.281 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.937 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:10 UTC |
Jafry Syed A.Director
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001745891-26-000004 · form4-05272026_080501.xml · derivative · entry 2 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,098 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:10 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001745891-26-000004 · form4-05272026_080501.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,288.638 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director F4 · balance_after: Includes 21.697 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:09 UTC |
HIGGINS ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,382 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:09 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001142083-26-000006 · form4-05272026_080517.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,357.322 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 106.777 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:08 UTC |
HAGEMANN ROBERTDirector
|
GrantRestricted Stock Units · Derivative | 1,517.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001222676-26-000008 · form4-05272026_080528.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,927 Underlying: Common Stock · 1,517.274 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:08 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 875.35 | $0.00 Strike: $85.68 | $0.00 |
DisclosureSEC source: 0001222676-26-000008 · form4-05272026_080528.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,952.074 Underlying: Common Stock · 875.35 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 93.883 phantom stock units accrued on April 30, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:08 UTC |
Stellato Paul AVP, Controller, CAO
|
GrantRestricted Stock Units · Derivative | 9,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000010 · form4-05052026_080504.xml · derivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,232 Underlying: Common Stock · 9,232 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on May 1, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing on May 1, 2027. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC |
Noor JehanzebSee remarks below.
|
Exercise / conversionRestricted Stock Units · Derivative | 6,626 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · derivative · entry 3 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,249 Underlying: Common Stock · 6,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028. F4 · derivative.expiration_date: One-third of the RSUs vested on April 1, 2026. The remaining RSUs vest one-half on each of April 1, 2027 and April 1, 2028. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC |
Noor JehanzebSee remarks below.
|
Tax withholdingCommon Stock | 1,677 | $90.67 | $152,053.59 |
DisclosureSEC source: 0002059755-26-000004 · form4-04032026_080411.xml · nonDerivative · entry 2 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,151 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding on the vesting of restricted stock units ("RSUs"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.